What boster.com does

BOSTER Biological Technology (博士德生物), founded in 1993 and headquartered in Wuhan, China, is a privately held manufacturer of life-science research reagents. Its core product lines are primary antibodies (monoclonal, polyclonal, loading control, tag, and phosphorylation antibodies), secondary antibodies (unlabeled, biotin-, enzyme-, and fluorescent-conjugated), ELISA kits (Human, Mouse, Rat, and other species), Western blot and immunohistochemistry detection reagents, molecular biology detection kits (including in situ hybridization and apoptosis), cell culture products (STR-authenticated cell lines, media, sera), and recombinant proteins. Underlying technology is classical immunoassay and antibody development — hybridoma-based monoclonal and polyclonal antibody production, ELISA kit development, and STR cell-line authentication — validated across WB, IHC, IF, ELISA, ICC, and FCM applications. The company supplements its catalog with custom antibody and custom media development services and contracted ELISA testing.

Commercially, BOSTER monetizes through unit-priced direct e-commerce sales via its domestic platform (boster.com) and its international platform (bosterbio.com), a nationwide authorized dealer network in China, and direct institutional sales to major universities and research centers. Pricing is transactional and promotional (e.g., ¥240/mg secondary antibodies, ¥1,280 FBS packs, ¥13,380 cell lines with volume discounts), reflecting a high-volume, low-average-order mix. Customer segments are horizontally distributed across life-science research institutions, universities, pharmaceutical/biotech drug-discovery groups, and academic laboratories in China and the US. The company reports 20,000+ antibody targets, 2,000+ ELISA kits, 80,000+ scientific literature citations, and 10,000+ research institutions served, with a wholly owned US subsidiary in Pleasanton, California serving North American customers.

Strategic posture is one of catalog breadth and channel coverage rather than platform or technology disruption. Recent observable moves include expansion into recombinant rabbit monoclonal antibodies, zebrafish-specific antibodies, high-sensitivity ELISA kits, and multi-plex immunofluorescence/flow cytometry reagents, alongside a 33rd-anniversary customer engagement campaign. No funding rounds, M&A, or leadership changes are disclosed, and there is no evidence of AI/ML-driven product capabilities. The business model is a traditional reagent catalog with an e-commerce-led, multi-channel distribution architecture.

Name

boster.com

Legal name

Wuhan Boster Biological Technology Co., Ltd. (武汉博士德生物工程有限公司)

Website

https://boster.com

Company type

Private

Founded year

1993

Operating status

Operating

Short description

BOSTER Biological Technology (博士德生物) is a privately held Wuhan-based manufacturer founded in 1993 that supplies antibodies, ELISA kits, and cell-culture reagents to more than 10,000 life-science research institutions globally via direct e-commerce, an authorized dealer network in China, and a US subsidiary in Pleasanton.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Antibody manufacturing
• ELISA kits
• Life science reagents
• Immunohistochemistry reagents
• Cell culture products

Headquarters

HQ city

Pleasanton

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Research Reagent Sales: Sale of antibodies, ELISA kits, cell culture products, and related biological reagents to research institutions and laboratories worldwide. Revenue generated through direct product sales via e-commerce platform and authorized distribution network.
2. Custom Product Services: Custom antibody development services including mouse monoclonal antibody customization, rabbit polyclonal antibody customization, in situ hybridization customization, and culture medium customization services.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

BOSTER Biological Technology manufactures and sells antibodies (primary and secondary), ELISA kits, Western blot and immunohistochemistry detection reagents, cell culture products (including STR-authenticated cell lines and sera), molecular biology detection kits, and recombinant proteins for life science research. The company also offers custom antibody development services (mouse monoclonal, rabbit polyclonal, in situ hybridization, custom culture media) and experimental testing services such as cell STR authentication and ELISA testing.

Product overview

BOSTER Biological Technology is a biotechnology company founded in 1993, specializing in the research, development, and manufacturing of biological reagents for life science research. The company offers a comprehensive portfolio of products centered around antibodies and ELISA assays, including primary antibodies (monoclonal, polyclonal, loading control, tag, and phosphorylation), secondary antibodies (unlabeled, biotin, enzyme, and fluorescent conjugates), ELISA kits for multiple species, and complementary detection reagents for Western blot, immunohistochemistry, immunofluorescence, flow cytometry, and molecular biology applications. The product line extends to cell culture products including authenticated cell lines, media, and sera, as well as recombinant proteins. In addition to products, BOSTER provides custom antibody development services and experimental testing services. The company reports over 20,000 antibody targets, 2,000+ ELISA reagents, and 80,000+ product citations in literature, serving over 10,000 research institutions globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Primary Antibodies
• Secondary Antibodies
• ELISA Kits
• Western Blot Detection Reagents
• Immunohistochemistry Detection Reagents
• Molecular Biology Detection Reagents
• Cell Culture Products
• Proteins and Reagents
• Custom Antibody Development Services
• Experimental Services

Quantifiable outcome

• 80,000+ scientific literature citations supporting product reliability
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Wuhan Fengwang (武汉丰网)minorOthersTechnical support partner providing website hosting and technical services for BOSTER's online platforms. Contact information provided as technical support on the BOSTER website.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about boster.com